Skip to main content
Erschienen in: Pediatric Nephrology 9/2009

01.09.2009 | Original Article

T regulatory cell function in idiopathic minimal lesion nephrotic syndrome

verfasst von: Carlos Araya, Leila Diaz, Clive Wasserfall, Mark Atkinson, Wei Mu, Richard Johnson, Eduardo Garin

Erschienen in: Pediatric Nephrology | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to test the hypothesis that, in idiopathic minimal lesion nephrotic syndrome (IMLNS), the T regulatory (T reg) cell suppressor mechanism is deficient, thereby enhancing cytokine release by T effector cells. Twenty-one patients with IMLNS, eight healthy controls and two patients with nephrotic syndrome and membranoproliferative glomerulonephritis were studied. The percentage of T reg cells was similar in the healthy controls and in patients with IMLNS in relapse or in remission. Thymidine incorporation in autologous T effector cells, as well as expression of the regulatory cytokine interleukin (IL)-10, was significantly reduced in patients in relapse when compared with patients in remission and healthy subjects. IL-2 expression was also reduced in patients in relapse but did not achieve statistical significance. In a different set of experiments, T cells, from subjects with IMLNS in remission, when stimulated with antiCD3-antiCD28 antibodies, secreted increased levels of cytokines. No such increase in cytokines was observed when cells from healthy controls were stimulated with same mitogen. The impaired T reg cell function observed in these patients may have pathogenic and therapeutic implications, because it could explain the persistence of the proposed pathogenic cytokines observed in the patients with IMLNS.
Literatur
1.
Zurück zum Zitat International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. A report rom the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. A report rom the International Study of Kidney Disease in Children. Kidney Int 13:159–165CrossRef
2.
Zurück zum Zitat Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556–603CrossRef Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556–603CrossRef
3.
Zurück zum Zitat Garin EH, Blanchard DK, Matsushima K, Djeu JY (1994) IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45:1311–1317CrossRef Garin EH, Blanchard DK, Matsushima K, Djeu JY (1994) IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45:1311–1317CrossRef
4.
Zurück zum Zitat Garin EH, Laflam PF, Muffly K (2006) Proteinuria and fusion of foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp Nephrol 102:105–112CrossRef Garin EH, Laflam PF, Muffly K (2006) Proteinuria and fusion of foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp Nephrol 102:105–112CrossRef
5.
Zurück zum Zitat Lai KW, Wei CL, Tan LK, Tan PH, Chiang GSC, Lee CGL, Jordan SC, Yap HK (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476–1485CrossRef Lai KW, Wei CL, Tan LK, Tan PH, Chiang GSC, Lee CGL, Jordan SC, Yap HK (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476–1485CrossRef
6.
Zurück zum Zitat Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453–460CrossRef Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453–460CrossRef
7.
Zurück zum Zitat Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J Immunol 172:34–39CrossRef Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR (2004) B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J Immunol 172:34–39CrossRef
8.
Zurück zum Zitat Finger EB, Bluestone JA (2002) When ligand becomes receptor—tolerance via B7 signaling on DCs. Nat Immunol 3:1056–1057CrossRef Finger EB, Bluestone JA (2002) When ligand becomes receptor—tolerance via B7 signaling on DCs. Nat Immunol 3:1056–1057CrossRef
9.
Zurück zum Zitat Oaks MK, Hallet KM (2000) Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015–5018CrossRef Oaks MK, Hallet KM (2000) Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015–5018CrossRef
10.
Zurück zum Zitat Churg J, Habib R, White HRH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet i:1299–1302CrossRef Churg J, Habib R, White HRH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet i:1299–1302CrossRef
11.
Zurück zum Zitat Brusko TN, Wasserfall CH, McGrail K, Schatz R, Viener HL, Schatz DA, Haller M, Rockell J, Gotlieb P, Clare-Salzler M, Atkinson MA (2007) No alterations in the frequency of FOXP3 + regulatory T-cells in type 1 diabetes. Diabetes 56:604–612CrossRef Brusko TN, Wasserfall CH, McGrail K, Schatz R, Viener HL, Schatz DA, Haller M, Rockell J, Gotlieb P, Clare-Salzler M, Atkinson MA (2007) No alterations in the frequency of FOXP3 + regulatory T-cells in type 1 diabetes. Diabetes 56:604–612CrossRef
12.
Zurück zum Zitat Shimon S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune response. Annu Rev Immunol 22:531–562CrossRef Shimon S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune response. Annu Rev Immunol 22:531–562CrossRef
13.
Zurück zum Zitat Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMed Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMed
14.
Zurück zum Zitat Fontenot JD, Gavin MA, Rudensky AY (2003) FoxP3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol 4:330–336CrossRef Fontenot JD, Gavin MA, Rudensky AY (2003) FoxP3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol 4:330–336CrossRef
15.
Zurück zum Zitat Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4 + CD25 high regulatory cells in human peripheral blood. J Immunol 167:1245–1253CrossRef Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4 + CD25 high regulatory cells in human peripheral blood. J Immunol 167:1245–1253CrossRef
16.
Zurück zum Zitat Yokoyama H, Kida H, Tani Y, Abe T, Tomosugi N, Koshino Y, Hattori N (1985) Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocytes subsets and serum immunoglobulin levels. Clin Exp Immunol 61:601–617PubMedPubMedCentral Yokoyama H, Kida H, Tani Y, Abe T, Tomosugi N, Koshino Y, Hattori N (1985) Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocytes subsets and serum immunoglobulin levels. Clin Exp Immunol 61:601–617PubMedPubMedCentral
17.
Zurück zum Zitat Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME (2002) T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958–965CrossRef Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME (2002) T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958–965CrossRef
18.
Zurück zum Zitat Daniel V, Trautmann Y, Konrad M, Nayir A, Scharer K (1997) T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47:289–297PubMed Daniel V, Trautmann Y, Konrad M, Nayir A, Scharer K (1997) T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 47:289–297PubMed
19.
Zurück zum Zitat Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242–247CrossRef Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242–247CrossRef
20.
Zurück zum Zitat Topaloglu R, Saatci U, Arikan M, Canpinar H, Bakkaloglu A, Kansu E (1994) T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8:649–652CrossRef Topaloglu R, Saatci U, Arikan M, Canpinar H, Bakkaloglu A, Kansu E (1994) T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8:649–652CrossRef
21.
Zurück zum Zitat Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ (1994) Lymphocyte subpopulations, interleukin-2, and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8:135–139CrossRef Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ (1994) Lymphocyte subpopulations, interleukin-2, and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8:135–139CrossRef
22.
Zurück zum Zitat Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2(IL-2). J Autoimmun 31:7–12CrossRef Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2(IL-2). J Autoimmun 31:7–12CrossRef
23.
Zurück zum Zitat Wakkach A, Augier S, Breittmayer JP, Blin-Wakkach C, Carle GF (2008) Characterization of IL-10 secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker. J Immunol 180:6054–6063CrossRef Wakkach A, Augier S, Breittmayer JP, Blin-Wakkach C, Carle GF (2008) Characterization of IL-10 secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker. J Immunol 180:6054–6063CrossRef
24.
Zurück zum Zitat Mottet C, Golshayan D (2007) CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly 137:625–634PubMed Mottet C, Golshayan D (2007) CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly 137:625–634PubMed
25.
Zurück zum Zitat Thornton AM, Shevach EM (1998) CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287–296CrossRef Thornton AM, Shevach EM (1998) CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287–296CrossRef
26.
Zurück zum Zitat Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F (2003) CD4 + CD25 + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111–119CrossRef Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F (2003) CD4 + CD25 + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111–119CrossRef
27.
Zurück zum Zitat Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE (1999) Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 13:199–204CrossRef Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE (1999) Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 13:199–204CrossRef
28.
Zurück zum Zitat Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J (1994) Increase of tumor necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 24:799–805CrossRef Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J (1994) Increase of tumor necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 24:799–805CrossRef
29.
Zurück zum Zitat Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259CrossRef Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259CrossRef
30.
Zurück zum Zitat Matsumoto K, Kanmatsuse K (1999) Increased IL-2 release by monocytes in nephrotic syndrome. Clin Exp Immunol 117:361–367CrossRef Matsumoto K, Kanmatsuse K (1999) Increased IL-2 release by monocytes in nephrotic syndrome. Clin Exp Immunol 117:361–367CrossRef
31.
Zurück zum Zitat Saxena S, Mittal A, Andal A (1993) Pattern of interleukins in minimal change nephrotic syndrome of childhood. Nephron 65:56–61CrossRef Saxena S, Mittal A, Andal A (1993) Pattern of interleukins in minimal change nephrotic syndrome of childhood. Nephron 65:56–61CrossRef
32.
Zurück zum Zitat Neuhaus TJ, Wadhwa M, Callard R, Barrat TM (1995) Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 100:475–479CrossRef Neuhaus TJ, Wadhwa M, Callard R, Barrat TM (1995) Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 100:475–479CrossRef
33.
Zurück zum Zitat Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529–537PubMed Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529–537PubMed
34.
Zurück zum Zitat Laflam PF, Haragushi S, Garin EH (2002) Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 increased IL-8 mRNA stability. Nephron 91:620–626CrossRef Laflam PF, Haragushi S, Garin EH (2002) Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 increased IL-8 mRNA stability. Nephron 91:620–626CrossRef
35.
Zurück zum Zitat Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefvt R, Coffman RL, Hawrylowicz CM, O’Garra A (2002) In Vitro generation of interleukin 10- producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T- helper type-1 (Th1) and Th2-inducing cytokines. J Exp Med 195:603–606CrossRef Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefvt R, Coffman RL, Hawrylowicz CM, O’Garra A (2002) In Vitro generation of interleukin 10- producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T- helper type-1 (Th1) and Th2-inducing cytokines. J Exp Med 195:603–606CrossRef
Metadaten
Titel
T regulatory cell function in idiopathic minimal lesion nephrotic syndrome
verfasst von
Carlos Araya
Leila Diaz
Clive Wasserfall
Mark Atkinson
Wei Mu
Richard Johnson
Eduardo Garin
Publikationsdatum
01.09.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 9/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1214-x

Weitere Artikel der Ausgabe 9/2009

Pediatric Nephrology 9/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.